Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

ClinicalTrials.gov ID: NCT00345631

Public ClinicalTrials.gov record NCT00345631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ECLIPSE Trial - Ensure's Vascular Closure Device Speeds Hemostasis Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level of safety.

Study identification

NCT ID
NCT00345631
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cordis US Corp.
Industry
Enrollment
488 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2007 (Type not available)
Primary completion
Not listed
Completion
Sep 2007 (Actual)
Last update posted
Jun 1, 2012

2007

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054 —
University of California Davis Medical Center Sacramento California 95817 —
Sutter Memorial Hospital Sacramento California 95819 —
Stanford University Stanford California 94305-5218 —
Morton Plant Hosptial Clearwater Florida 33756 —
The Care Group Indianapolis Indiana 46290 —
Washington University School of Medicine at Barnes-Jewish Hospital St Louis Missouri 63110 —
Cooper Health Systems Camden New Jersey 08103 —
SJH Cardiology Associates Liverpool New York 13088 —
New York Presbyterian Hospital - Cornell Medical College of Cornell University New York New York 10021 —
Wake Heart Research Raleigh North Carolina 27610 —
University Hospitals of Cleveland Cleveland Ohio 44122 —
Hahnemann Hospital Philadelphia Pennsylvania 19102 —
Moffitt Heart & Vascular Group Wormleysburg Pennsylvania 17043 —
Baylor Research Institute Dallas Texas 75226 —
LDS Hospital Salt Lake City Utah 84143 —
Swedish Medical Center Seattle Washington 98117 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00345631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2012 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00345631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →